SCHEMBL7865523

SCHEMBL7865523

CCOc1ccc(C(Cl)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.57
KIF11 P52732 1/20 0.55
NQO1 P15559 1/20 0.54
RELA Q04206 1/20 0.52
TSHR P16473 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TP53 P04637 2/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
GAA P10253 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6423852 1.00 LTA4H (0.57) LTA4HKIF11NQO1RELATSHR
SCHEMBL12128744 0.82 SMN1; SMN2 (0.64) LTA4HKIF11NQO1RELATDP1
SCHEMBL18302044 0.81 LTA4H (0.60) LTA4HTSHRSMN1; SMN2ALDH1A1TP53
SCHEMBL9304906 0.81 LTA4H (0.60) LTA4HTSHRSMN1; SMN2ALDH1A1TP53
SCHEMBL6566848 0.81 LTA4H (0.57) LTA4HKIF11NQO1RELATSHR
SCHEMBL121800 0.78 CA4 (0.54) LTA4HKIF11TSHRTDP1SMN1; SMN2
SCHEMBL26862 0.78 CA4 (0.54) LTA4HKIF11TSHRTDP1SMN1; SMN2
SCHEMBL16698731 0.78 CA4 (0.54) LTA4HKIF11TSHRTDP1SMN1; SMN2
Phenetole SCHEMBL18492 0.76
Phenetole SCHEMBL10779391 0.76 LTA4H (0.81) LTA4HNQO1RELATSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001071008-A1 ANTISENSE INHIBITION OF ADAM10 EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2001-09-27 WO disclosed
EP-0774902-A1 ANTISENSE AND TRIPLEX THERAPEUTIC AGENTS AND METHODS Altman, Sidney (US) 1997-05-28 EP disclosed
WO-1996004788-A1 ANTISENSE AND TRIPLEX THERAPEUTIC AGENTS AND METHODS ALTMAN SIDNEY (US) 1996-02-22 WO disclosed
EP-0542928-A4 IMPROVED NON-NUCLEOTIDE-BASED LINKER REAGENTS FOR OLIGOMERS GENTA INC (US) 1994-07-27 EP disclosed
EP-0542928-A1 IMPROVED NON-NUCLEOTIDE-BASED LINKER REAGENTS FOR OLIGOMERS GENTA INCORPORATED (US) 1993-05-26 EP disclosed
EP-0428707-A4 STEROID MODIFIED OLIGONUCLEOTIDES 1992-05-20 EP disclosed
WO-1990003370-A1 DERIVATIVES OF PYRAZOLO[3,4-d]PYRIMIDINE MICROPROBE CORPORATION (US) 1990-04-05 WO disclosed
EP-0219532-A4 APPARATUS FOR AUTOMATED SYNTHESIS OF PEPTIDES. APPLIED PROTEIN TECHNOLOGIES (US) 1988-03-30 EP disclosed
EP-0219532-A1 APPARATUS FOR AUTOMATED SYNTHESIS OF PEPTIDES. APPLIED PROTEIN TECHNOLOGIES (US) 1987-04-29 EP disclosed
WO-1986006298-A1 METHOD AND APPARATUS FOR AUTOMATED SYNTHESIS OF PEPTIDES APPLIED PROTEIN TECHNOLOGIES, INC. (US) 1986-11-06 WO disclosed